GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression

3M ago

GHRS

PremiumPress Releases

GH Research Reports Third Quarter Financial Results and Provides Business Updates

6M ago

GHRS

PremiumPress Releases

GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression

7M ago

GHRS

PremiumPress Releases

GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates

8M ago

GHRS

PremiumStock Analysis & Ideas

‘It’s Really a Brain Chemistry Issue’: Elon Musk Embraces Ketamine in the Battle Against Depression — Here Are 2 Psychedelic Stocks That Analysts Like

10M ago

CMPS

GHRS

PremiumPre-Earnings

GHRS Earnings this Week: How Will it Perform?

12M ago

GHRS

More GHRS News >

GHRS News on the Web

2024-04-23

Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week

TalkMarkets

Neutral

2024-04-12

Largest Psychedelic Drug Stocks Up Another 10% Last Week; Now Up 54% YTD

TalkMarkets

Neutral

2024-03-30

March Recap: Largest Psychedelic Drug Stocks Up Another 5%

TalkMarkets

Neutral

2024-03-11

Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week

TalkMarkets

Neutral

2024-03-05

How Much Upside is Left in GH Research PLC ? Wall Street Analysts Think 321.28%

Yahoo Finance

Bullish

2024-03-05

How Much Upside is Left in GH Research PLC (GHRS)? Wall Street Analysts Think 321.28%

Zacks

Bullish

2024-03-04

Buy Rating for GH Research: Promising Clinical Trials and Strategic Intellectual Property Advances

TipRanks News

Bullish

2024-03-01

Largest Psychedelic Compound-Based Drug Stocks Up 15% In February; Now Up 33% YTD

TalkMarkets

Neutral

News Score - Last 7 Days

Neutral

GHRS

Sector Average

Media Buzz

This Week1 articles

Weekly Average1 articles

News Sentiment

This Week50%

Sector Average59%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GHRS’s Media Buzz Sentiment?

1 articles about GHRS were published this week. In an average week, 1 articles are published.

What is GHRS’s weekly average amount of articles?

In an average week, 1 articles about GHRS are published.

What is GHRS’s News Sentiment?

50% of articles about GHRS were positive this week, compared to its sector average of 59%.

Healthcare Stocks that are Trending in the News

DAWNDay One Biopharmaceuticals

RMDResmed

TAKTakeda Pharmaceutical Company

IMVTImmunovant

NBIXNeurocrine

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing